Estradiol assays--The path ahead

Area of Science:

• Clinical chemistry
• Endocrinology
• Assay development

Background:

• Estradiol quantitation is vital for assessing various endocrine disorders and treatment responses.
• Current direct immunoassays struggle with accuracy and specificity at low estradiol concentrations, particularly in pediatric/male patients and during aromatase inhibitor therapy.
• Physiologically relevant estradiol levels vary widely, necessitating assays with broad dynamic range and high sensitivity.

Purpose of the Study:

• To review the historical development of estradiol assays, from radioimmunoassays to modern liquid-chromatography tandem mass spectrometry (LC-MS/MS).
• To discuss technical considerations for optimizing LC-MS/MS assays for estradiol measurement.
• To present an ultra-sensitive LC-MS/MS assay with a low limit of quantitation for estradiol.

Main Methods:

• Review of existing literature on estradiol assay methodologies.
• Discussion of technical factors influencing LC-MS/MS assay performance.
• Presentation of data from a newly developed ultra-sensitive LC-MS/MS estradiol assay.

Main Results:

• Direct immunoassays exhibit limitations in accuracy and specificity, especially at low estradiol levels.
• LC-MS/MS offers improved accuracy and specificity compared to immunoassays.
• An optimized LC-MS/MS assay achieved a limit of quantitation of 0.2 pg/mL for estradiol.

Conclusions:

• LC-MS/MS represents a significant advancement in estradiol quantitation, overcoming limitations of traditional immunoassays.
• The developed ultra-sensitive LC-MS/MS assay provides accurate and specific estradiol measurements across a wide physiological range.
• This improved assay is crucial for challenging clinical scenarios requiring precise low-level estradiol determination.